3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Urinary Bladder Neoplasms
3
Prostatic Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Adenocarcinoma Of Esophagus
3
Stomach Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Squamous Cell
2
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Sarcoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Mesothelioma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Interventions
Gemcitabine
6
Docetaxel
3
durvalumab
2
Mitomycin
2
viscum album peptide
1
tremelimumab
1
pembrolizumab
1
erdafitinib
1
avelumab
1
VPM1002 recombinant BCG vaccine
1
Neoadjuvant Therapy
1
Monatide (IMS 3015)
1
Mitozytrex
1
House Calls
1
Home Care Services
1
Dihematoporphyrin Ether
1
DDMS
1
Cystoscopy
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
BCG Vaccine
1
Administration, Intravesical
1
ALT-803
1
ALT-801
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Non-Muscle Invasive Bladder Neoplasms
×
tremelimumab
×
Clear all
NCT03317158
2026-04-15
ADAPT-BLADDER
Hoosier Cancer Research Network
Phase 1/2
Recruiting
55 enrolled